Study guide

5.2 Organogenesis: Cardiovascular and Respiratory System Development

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

5.2 Organogenesis: Cardiovascular and Respiratory System Development

Key Takeaways Explain This Topic AI

Cardiovascular development begins in week 3; primitive heart tube dextral looping establishes normal anatomical orientation.

Atrial septation involves septum primum, ostium secundum, septum secundum, and the foramen ovale, creating a vital right-to-left fetal shunt.

Membranous ventricular septal defect (VSD) is the most common congenital cardiac anomaly, arising from incomplete fusion of endocardial cushions and aorticopulmonary septum.

Fetal circulation relies on three shunts (ductus venosus, foramen ovale, ductus arteriosus) that close functionally at birth and convert to adult ligamentous remnants.

Surfactant production by Type II pneumocytes begins around gestational week 26 but reaches mature protective levels near week 35; deficiency causes Neonatal Respiratory Distress Syndrome.

Last updated: July 2026

5.2 Organogenesis: Cardiovascular and Respiratory System Development

The cardiovascular system is the first organ system to reach functional capacity in the human embryo, beginning coordinated contractions by day 21 to 22. Respiratory development proceeds concurrently through distinct histological stages, preparing the fetus for the rapid transition to aerial respiration at birth.

  • Cardiovascular Embryology
  • Heart Tube Looping and Left-Right Asymmetry

During week 4, the linear primary heart tube undergoes dextral (rightward) looping to position the primitive atrium dorsally and the primitive ventricle ventrally. This directional bending relies on cilia-driven asymmetrical signaling of Nodal and Lefty genes.

Clinical Connection : Defective ciliary dynein motors disrupt left-right body axis specification. This causes Kartagener syndrome (primary ciliary dyskinesia), characterized by situs inversus (heart and organs inverted), chronic sinusitis, bronchiectasis, and male infertility due to immotile sperm flagella.

Atrial Septation

Partitioning of the common atrium involves a synchronized sequence of septum growth and programmed cell death: Septum Primum grows down toward Cushion → Ostium Primum narrows

  • → Apoptosis forms Ostium Secundum → Septum Secundum grows alongside
  • → Foramen Ovale acts as one-way valve (Right-to-Left Shunt)

Septum Primum grows from the roof of the common atrium toward the endocardial cushions, leaving an opening called the ostium primum .

Before the ostium primum fully closes, apoptosis creates perforations in the upper septum primum that coalesce into the ostium secundum .

Septum Secundum develops to the right of the septum primum. It covers the ostium secundum but leaves a crescentic lower opening: the foramen ovale .

The remaining flexible lower portion of septum primum acts as a one-way valve, allowing oxygenated blood to flow from right to left atrium during fetal life.

Ventricular Septation and VSD

Ventricular septation requires dual tissue participation:

Muscular Ventricular Septum : Grows superiorly from the floor of the primitive ventricle.

Membranous Ventricular Septum : Formed by the fusion of the neural crest-derived aorticopulmonary septum with the endocardial cushions and muscular septum.

A membranous Ventricular Septal Defect (VSD) is the single most common congenital cardiac anomaly. Incomplete fusion of these components leads to left-to-right shunting postnatally, causing pulmonary hypertension and eventual Eisenmenger syndrome if unrepaired.

Aortic Arch Derivatives

The pharyngeal arch arteries undergo extensive remodeling between weeks 4 and 8 to form the major arterial pathways:

  • Arch Number Vascular Derivative Mnemonic
  • 1st Arch Part of maxillary artery (branch of external carotid) 1st arch is 1st (Maxillary)
  • 2nd Arch Stapedial artery and hyoid artery 2nd = Stapedial (Stapes)
  • 3rd Arch Common carotid artery and proximal internal carotid artery 3rd = Carotid (C is 3rd letter)
  • 4th Arch Left : Aortic arch; Right : Proximal right subclavian artery 4th = Arch & Subclavian
  • 6th Arch Proximal pulmonary arteries ; Left 6th : Ductus arteriosus 6th = Pulmonary & Ductus
  • Fetal Circulation and Postnatal Remnants

Fetal circulation is designed to divert oxygenated placental blood away from unventilated fetal lungs and non-functional GI tract directly toward the brain and systemic organs. Placenta → Umbilical Vein → Ductus Venosus (bypasses liver) → IVC → Right Atrium

  • ├─→ Foramen Ovale → Left Atrium → Left Ventricle → Systemic Circulation (Brain)
  • └─→ Right Ventricle → Pulmonary Trunk → Ductus Arteriosus → Descending Aorta
  • Postnatal Circulatory Changes

At birth, lung inflation decreases pulmonary vascular resistance, while clamping the umbilical cord increases systemic vascular resistance. This pressure shift reverses atrial gradients, snapping the septum primum against septum secundum to close the foramen ovale functionally.

  • Fetal Structure Function in Fetus Adult Remnant
  • Umbilical Vein Carries oxygenated blood from placenta to fetus Ligamentum teres hepatis (round ligament)
  • Ductus Venosus Shunts blood from umbilical vein to IVC (bypassing liver) Ligamentum venosum
  • Foramen Ovale Shunts blood from right to left atrium Fossa ovalis
  • Ductus Arteriosus Shunts blood from pulmonary trunk to descending aorta Ligamentum arteriosum
  • Umbilical Arteries Carry deoxygenated blood from fetus to placenta Medial umbilical ligaments

Pharmacological Control : Indomethacin (an NSAID) inhibits prostaglandin synthesis and promotes closure of a Patent Ductus Arteriosus (PDA). Conversely, Prostaglandin E1 (alprostadil) keeps the ductus arteriosus open in ductal-dependent cyanotic heart lesions (e.g., transposition of great arteries).

Respiratory Embryology

The respiratory system begins at week 4 as the respiratory diverticulum (lung bud) , an outgrowth of the ventral wall of the foregut endoderm.

Five Stages of Lung Maturation Pseudoglandular (Wk 5-16) → Canalicular (Wk 16-26) → Saccular (Wk 26-Birth) → Alveolar (8 Mo - 8 Yrs)

Embryonic Period (Weeks 4–7) : Lung bud develops, bifurcates into lobar bronchi buds, and forms segmentations.

Pseudoglandular Period (Weeks 5–16) : Branching down to terminal bronchioles occurs. Respiration is impossible; fetus cannot survive.

Canalicular Period (Weeks 16–26) : Respiratory bronchioles and alveolar ducts form. Capillary network expands. Type II pneumocytes differentiate and begin producing surfactant around week 26 . Respiration becomes possible at the end of this phase with intensive care.

Saccular / Terminal Sac Period (Week 26 to Birth) : Terminal sacs (primitive alveoli) develop and thin out. Capillaries establish close contact with the alveolar basement membrane.

Alveolar Period (8 Months Gestation to 8 Years) : Mature alveoli multiply rapidly. Approximately 90% of mature alveoli develop postnatally.

Neonatal Respiratory Distress Syndrome (NRDS)

NRDS (hyaline membrane disease) is caused by a structural deficiency of surfactant , primarily dipalmitoylphosphatidylcholine (lecithin) , secreted by Type II pneumocytes.

Surfactant Kinetics : Surfactant reduces alveolar surface tension, preventing atelectasis at end-expiration. Production ramps up significantly after week 32, reaching mature protective levels around week 35 (demonstrated by a lecithin-to-sphingomyelin ratio L/S ratio ≥ \ge ≥ 2.0 in amniotic fluid).

Risk Factors : Prematurity, maternal diabetes (fetal hyperinsulinemia inhibits cortisol-mediated surfactant synthesis), and cesarean delivery without labor.

Pathophysiology : High surface tension causes alveolar collapse, hypoxia, endothelial damage, and fibrin accumulation (forming hyaline membranes).

Treatment : Antenatal corticosteroids ( betamethasone ) administered to mother to stimulate surfactant production; postnatal administration of exogenous surfactant and CPAP.